Lecture 1 - Transplant Immunosupression Flashcards
Induction Agent general info
potent
used at time of transplant, and few days after
Maintenance Agents general info
live long agents
Rejection Treatment general info
used for rejection..duh
Available induction agents
Monoclonal antibodies:
Alemtuzmab (Campath) = T cell depleting
Basiliximab (Simulect) = Non-T cell depleting
Polyclonal:
Equine anti-thymocyte globulin (ATGAM) = T cell depleting
Rabbit anti-thymocyte globulin (Thymoglobulin) = T cell depleting
Basiliximab (Simulect) info
Monoclonal
Non-depleting
Targets IL-2 receptor
Basiliximab (simplest) dosing info
20mg IV on Day 0 and 4
No need for premedication
half life 7 days, in body for 3-5weeks b4 need maintenance therapy
Good for pts high risk for complications too much immunosuppression
What receptors do Anti-Thymocyte Globulins target
CD28
IL-2
CD3
CD4
T cell receptor
Which Anti-Thymocyte Globulin is used in transplant pts? Horse or rabbit
Rabbit, shown to be superior in preventing rejection
Horse has a lot of toxicities too
Anti-Thymocyte Globulin rabbit dosing
1-1.5mg/kg/day
Induction = 3-5 doses
Rejection = 5-7 doses
req premed with steroids, Benadryl, Tylenol
Anti-Thymocyte Globulin Rabbit adverse reactions
Malignancy + infection
Infusion associated reactions
Leukopenia + thrombocytopenia
Half dose = WBC 2-3, platelets 50-75
Hold dose = WBC < 3, platelets < 50
How long for immune system to rebound Anti-Thymocyte Globulin rabbit?
2-3 months, takes awhile
Serum sickness Anti-Thymocyte Globulin Rabbit
4-14 days after exposure to med
inc risk if prior rabbit exposure
can lead to renal dysfunction through the formation of Ab-Ag complexes
Fever, myalgia, artralgia, malaise,itchy skin, rash
Infusion related Reactions Anti-Thymocyte Globulin Rabbit
occurs with 1/2nd infusion, manageable w/ reduce in infusion rate
Alemtuzumab (Campath) targets what receptor
CD52
Alemtuzumab (Campath) Dosing
30mg X 1 at transplant
Premed req w/ steroids, Benadryl, tylenol
Alemtuzumab (Campath) Adverse reactions
Leukopenia
Malignancy + infections
Infusion reactions if IV
Alemtuzumab (Campath) considerations
profound depletion of lymphocytes that can last up to 1 yr
Alemtuzumab (Campath) requirement for therapy
centers have to be enrolled in cam path distribution program
When is Thyroglobulin or Campath preferred?
High immunologic risk patients
ie…. young, autoimmune disease, steroid withdrawal protocols
** Low risk for complications of immunosuppression***
When is Simulect preferred?
Low immunologic risk patients
ie… 1 haplotype match (sibling/parent), > 70yrs, prior cancer/infection/organ transplant
** high risk for complications of immunosuppression ***
Primary agents maintenance
Tacrolimus***
Cylcosporine
Belatacept
Sirolimus
Everolimus
Secondary Agents maintenance
Mycophenolate mofetil/sodium***
Azathioprine
Everolimus
Sirolimus
Tertiary agent maintenance
+/- corticosteroids
Tacrolimus MOA basics
Blocks calcineuron, cant produce more inflammatory cytokines
binds to FKBP
Cyclosporine MOA basics
Blocks calcineuron, cant produce more inflammatory cytokines
Binds to cyclophillin
Tacrolimus formulations
Prograf = IR
Envarsus XR = once dialy
Astragraf XL = once daily
Prograf dosing
0.1-0.2 mg/kg/day orally in 2 equally divided doses…12hrs apart
Prograf IV dose adjustment
1/3 to 1/5 of oral dose
Sublingual Prograf dose adjustment
1/2 of oral dose
Tacrolimus monitoring
trough monitoring, goals of 5-12
Tacrolimus DI
CYP3A4, caution w/ inducers and inhibitors
Sublingual Tacrolimus info
Given to someone who is NPO or N/V
Essentially take capsule, open and pour under tongue
give 1/2 of oral dose
major side effect of tacrolimus?
Tremor, occurs in 30-50% of kidney transplant
occurs at peak tacrolimus concentrations
Benefits seen with Envarsus Tacrolimus?
Reduced peak = less tremors
Longer time to T max
Higher bioavail
Less % fluctuations in troughs
Prograf to Envarsus XR dose
Reduce Total daily dose by 20%